Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461)
Clinical trial NCT03368053 · COMPLETED
Trial details
- NCT number
- NCT03368053
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-14
- Primary completion
- 2018-01-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.